The offering initially provides for the primary distribution of 36,697,248 new shares, in addition to the sale of Genome VI shares
the pharmaceutical company I livewhich became public in August 2021, reported this Monday 24 that he had filed with the Securities and Exchange Commission (CVM) application for registration of the public offering of primary and secondary distribution of shares. Based on the closing price of the shares on July 21, equal to R$21.80, the total amount of the offer could reach R$800 million, without considering the placement of additional shares, and R$1.4 billion, considering the extra lots.
The offering initially provides for the primary distribution of 36,697,248 new shares. The secondary offering involves the sale of shares in Genoma VI Fundo de Investimento em Participações Multiestratégia.
The offer will be implemented under the coordination of Itaú BBA, BTG Pactual, UBS Brasil, Citigroup Global, Bradesco BBI, Santander (Brazil), Bank of America and Goldman Sachs do Brasil.
Source: Terra
Rose James is a Gossipify movie and series reviewer known for her in-depth analysis and unique perspective on the latest releases. With a background in film studies, she provides engaging and informative reviews, and keeps readers up to date with industry trends and emerging talents.
